Table 3

Multiple regression model for the association of baseline factors with gain in BCVA from baseline at months 12 and 24

ParameterEstimateP value
Month 12
 Intercept37.179<0.0001
 Treatment (0.5 mg vs control)18.856<0.0001
 Study (ANCHOR vs MARINA)−3.6660.0059
 Lesion size (DA)−1.207<0.0001
 Baseline BCVA (letters)−0.395<0.0001
 Age (years)−0.281<0.0001
Month 24
 Intercept42.011<0.0001
 Treatment (0.5 mg vs control)21.156<0.0001
 Lesion size (DA)−1.128<0.0001
 Baseline BCVA (letters)−0.456<0.0001
 Age (years)−0.363<0.0001
  • BCVA, best-corrected visual acuity; DA, disc area